Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

William S. Rilling MD

William S. Rilling MD

Vice Chair, Professor

Institution: Medical College of Wisconsin
Department: Radiology
Division: Vascular and Interventional Radiology
Program: General

Member of the Cancer Center


Publications

  • Palliative Interventional Oncology. (Fairchild AH, Rilling WS) Cancer J 2016 Nov/Dec;22(6):411-417 PMID: 27870684 11/22/2016
  • Geniculate Artery Embolization for Management of Recurrent Hemarthrosis: A Single-Center Experience. (Ogilvie ME, Tutton SM, Neilson JC, Rilling WS, Hohenwalter EJ) J Vasc Interv Radiol 2016 Jul;27(7):1097-9 PMID: 27338503 06/25/2016
  • Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. (Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF) Hepatology 2016 Jul;64(1):106-16 PMID: 26765068 01/15/2016
  • Evaluation of catheter infection rates in converted dialysis catheters versus de novo placement in the setting of chlorhexidine use. (Criddle JM, Hieb RA, White SB, Patel PJ, Hohenwalter EJ, Tutton SM, Rilling WS) J Vasc Access 2016 Mar-Apr;17(2):162-6 PMID: 26660045 12/15/2015
  • 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. (Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini J, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, Kauffman S, Kwan S, Padia SA, Gates VL, Mulcahy M, Kircher S, Nimeiri H, Benson AB, Salem R) J Nucl Med 2016 May;57(5):665-71 PMID: 26635340 12/05/2015
  • Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis. (Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK) PLoS One 2015;10(10):e0139940 PMID: 26448327 PMCID: PMC4598149 10/09/2015
  • Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. (de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC) Cardiovasc Intervent Radiol 2016 Mar;39(3):334-43 PMID: 26390875 09/24/2015
  • Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. (Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter EJ) HPB (Oxford) 2015 Aug;17(8):707-12 PMID: 26172137 PMCID: PMC4527856 07/15/2015
  • Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. (Martin RC 2nd, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM) Cancer 2015 Oct 15;121(20):3649-58 PMID: 26149602 07/08/2015
  • Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. (Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB) Cancer 2015 Oct 01;121(19):3491-8 PMID: 26096694 PMCID: PMC4578219 06/23/2015
  • A single-center experience in capturing inpatient evaluation and management for an IR practice. (White SB, Dybul SL, Patel PJ, Hohenwalter EJ, Hieb RA, Shah SP, Rilling WS, Tutton SM) J Vasc Interv Radiol 2015 Jul;26(7):958-62 PMID: 25937297 05/06/2015
  • Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. (Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA, SIRFLOX Study Group) BMC Cancer 2014 Dec 01;14:897 PMID: 25487708 PMCID: PMC4289171 12/10/2014
  • Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. (North DA, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Rilling WS, Gamblin TC, Martin RC) Am J Surg 2014 Aug;208(2):284-94 PMID: 24970652 06/28/2014
  • Percutaneous in utero thoracoamniotic shunt creation for fetal thoracic abnormalities leading to nonimmune hydrops. (White SB, Tutton SM, Rilling WS, Kuhlmann RS, Peterson EL, Wigton TR, Ames MB) J Vasc Interv Radiol 2014 Jun;25(6):889-94 PMID: 24702750 PMCID: PMC4671206 04/08/2014
  • Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. (Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O'Grady E, Rilling WS, Walker D, Martin RC) J Vasc Interv Radiol 2014 Mar;25(3):365-9 PMID: 24581461 03/04/2014
  • Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. (Zechlinski JJ, Rilling WS) Semin Intervent Radiol 2013 Mar;30(1):21-7 PMID: 24436514 PMCID: PMC3700793 01/18/2014
  • Endovascular management of a traumatic renal-caval arteriovenous fistula in a pediatric patient. (Kuy S, Rossi PJ, Seabrook GR, Brown KR, Lewis BD, Rilling WS, Martin G, Patel B, Dua A, McMaster J, Desai S, Lee CJ) Ann Vasc Surg 2014 May;28(4):1031.e1-5 PMID: 24360940 12/24/2013
  • Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric vein. (Pilgrim CH, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, Christians KK) J Gastrointest Surg 2014 May;18(5):917-21 PMID: 24347313 12/19/2013
  • Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. (Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC) J Surg Oncol 2014 Feb;109(2):95-7 PMID: 24122764 10/15/2013
  • Microwave ablation for hepatic malignancies: a multiinstitutional analysis. (Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC) Ann Surg 2014 Jun;259(6):1195-200 PMID: 24096760 10/08/2013
  • Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study. (Benson AB 3rd, Geschwind JF, Mulcahy MF, Rilling W, Siskin G, Wiseman G, Cunningham J, Houghton B, Ross M, Memon K, Andrews J, Fleming CJ, Herman J, Nimeiri H, Lewandowski RJ, Salem R) Eur J Cancer 2013 Oct;49(15):3122-30 PMID: 23777743 06/20/2013
  • Recurrence after microwave ablation of liver malignancies: a single institution experience. (Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS, Gamblin TC) HPB (Oxford) 2013 May;15(5):365-71 PMID: 23458599 PMCID: PMC3633038 03/06/2013
  • Pleural tumor seeding following percutaneous cryoablation of hepatocellular carcinoma. (Conners D, Rilling W) Semin Intervent Radiol 2011 Jun;28(2):258-60 PMID: 22654274 PMCID: PMC3193330 06/02/2012
  • Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? (Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA) AJR Am J Roentgenol 2011 Aug;197(2):334-40 PMID: 21785078 PMCID: PMC4063295 07/26/2011
  • Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. (Kiefer MV, Albert M, McNally M, Robertson M, Sun W, Fraker D, Olthoff K, Christians K, Pappas S, Rilling W, Soulen MC) Cancer 2011 Apr 01;117(7):1498-505 PMID: 21425151 03/23/2011
  • Research reporting standards for radioembolization of hepatic malignancies. (Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB 3rd, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A, Technology Assessment Committee, Interventional Oncology Task Force of the Society of Interventional Radiology) J Vasc Interv Radiol 2011 Mar;22(3):265-78 PMID: 21353979 PMCID: PMC4337835 03/01/2011
  • Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. (Wible BC, Rilling WS, Drescher P, Hieb RA, Saeian K, Frangakis C, Chen Y, Eastwood D, Kim HS) J Vasc Interv Radiol 2010 Jul;21(7):1024-30 PMID: 20621715 07/14/2010
  • Technical success and safety of retrieval of the G2 filter in a prospective, multicenter study. (Binkert CA, Drooz AT, Caridi JG, Sands MJ, Bjarnason H, Lynch FC, Rilling WS, Zambuto DA, Stavropoulos SW, Venbrux AC, Kaufman JA) J Vasc Interv Radiol 2009 Nov;20(11):1449-53 PMID: 19875062 10/31/2009
  • Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. (Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC, Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation) J Vasc Interv Radiol 2009 Jul;20(7 Suppl):S425-34 PMID: 19560030 07/09/2009
  • Resonance metallic ureteral stents do not successfully treat ureteroenteric strictures. (Garg T, Guralnick ML, Langenstroer P, See WA, Hieb RA, Rilling WS, Sudakoff GS, O'Connor RC) J Endourol 2009 Jul;23(7):1199-201; discussion 1202 PMID: 19530950 06/18/2009
  • Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy. (Hieb RA, Neisen MJ, Hohenwalter EJ, Molnar JA, Rilling WS) J Vasc Interv Radiol 2008 Dec;19(12):1704-8 PMID: 18951046 10/28/2008
  • Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization. (Fenske TS, Benjamin H, Kroft SH, Hohenwalter EJ, Rilling WS) Nat Clin Pract Oncol 2008 Nov;5(11):677-81 PMID: 18797436 09/18/2008
  • The extent of lower extremity occlusive disease predicts short- and long-term patency following endovascular infrainguinal arterial intervention. (Hasanadka R, Brown KR, Rilling WS, Rossi PJ, Hieb RA, Hohenwalter EJ, Seabrook GR, Lewis BD, Towne JB) Am J Surg 2008 Nov;196(5):629-33 PMID: 18789419 09/16/2008
  • Hepatic neuroendocrine metastases: chemo- or bland embolization? (Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H, Rilling WS, Quebbeman EJ, Agarwal DM, Pitt HA) J Gastrointest Surg 2008 Nov;12(11):1951-60 PMID: 18709512 PMCID: PMC3342849 08/19/2008
  • Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. (Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC) J Vasc Interv Radiol 2007 Dec;18(12):1469-78 PMID: 18057279 12/07/2007
  • Psychosocial management of distress in interventional radiology patients with cancer. (Sims MJ, Rilling WS) Tech Vasc Interv Radiol 2006 Sep;9(3):101-5 PMID: 17561212 06/15/2007
  • Radioembolization with 90Y microspheres: angiographic and technical considerations. (Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R) Cardiovasc Intervent Radiol 2007 Jul-Aug;30(4):571-92 PMID: 17516113 05/23/2007
  • Interventional radiology training: current status and the rationale for change. (Rilling WS) J Vasc Interv Radiol 2006 Nov;17(11 Pt 2):S159-62 PMID: 17142698 12/05/2006
  • Combining local and regional therapeutic modalities to treat hepatic malignancies. (Rilling WS, Hohenwalter EJ) Semin Intervent Radiol 2006 Mar;23(1):33-8 PMID: 21326718 PMCID: PMC3036303 03/01/2006
  • Chemoembolization in patients at high risk: results and complications. (Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA) J Vasc Interv Radiol 2006 Jan;17(1):47-53 PMID: 16415132 01/18/2006
  • Bland embolization of telangiectatic subtype of hepatic focal nodular hyperplasia. (Gussick SD, Quebbeman EJ, Rilling WS) J Vasc Interv Radiol 2005 Nov;16(11):1535-8 PMID: 16319163 12/02/2005
  • IVC stent deployment via translumbar approach. (Wible BC, Hieb R, Halum R, Rilling W) J Vasc Interv Radiol 2005 May;16(5):733-6 PMID: 15872329 05/06/2005
  • Neuroendocrine hepatic metastases: does aggressive management improve survival? (Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA) Ann Surg 2005 May;241(5):776-83; discussion 783-5 PMID: 15849513 PMCID: PMC1357132 04/26/2005
  • SIR 2004 Film Panel Case: hereditary hemorrhagic telangiectasia of the liver with mesenteric steal. (Rilling WS, Wible BC) J Vasc Interv Radiol 2004 Dec;15(12):1375-9 PMID: 15590791 12/14/2004
  • Preoperative embolization. (Rilling WS, Chen GW) Semin Intervent Radiol 2004 Mar;21(1):3-9 PMID: 21331104 PMCID: PMC3036207 03/01/2004
  • Arterial puncture closure using a collagen plug, I. (Angio-Seal). (Rilling WS, Dicker M) Tech Vasc Interv Radiol 2003 Jun;6(2):76-81 PMID: 12903000 08/07/2003
  • Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab. (Drescher P, McGuckin J, Rilling WS, Crain MR) AJR Am J Roentgenol 2003 May;180(5):1385-91 PMID: 12704056 04/22/2003
  • Improved survival in resected biliary malignancies. (Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, Wilson SD, Demeure MJ, Rilling WS, Dua KS, Pitt HA) Surgery 2002 Oct;132(4):555-63; discission 563-4 PMID: 12407338 10/31/2002
  • Multidisciplinary management of hepatocellular carcinoma. (Rilling WS, Drooz A) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S259-63 PMID: 12354844 10/02/2002
  • Hepatocellular carcinoma: obligation and opportunity for interventional radiology. (Geschwind JF, Rilling WS) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S167 PMID: 12354832 10/02/2002
  • Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. (Drescher P, Crain MR, Rilling WS) J Vasc Interv Radiol 2002 Jan;13(1):37-43 PMID: 11788692 01/15/2002
  • Renal transplant evaluation with MR angiography and MR imaging. (Hohenwalter MD, Skowlund CJ, Erickson SJ, Hariharan S, Rilling WS, Crain MR, Drescher P) Radiographics 2001 Nov-Dec;21(6):1505-17 PMID: 11706221 11/14/2001
  • Hepatocellular carcinoma: multimodality management. (Christians KK, Pitt HA, Rilling WS, Franco J, Quiroz FA, Adams MB, Wallace JR, Quebbeman EJ) Surgery 2001 Oct;130(4):554-9; discussion 559-60 PMID: 11602884 10/17/2001
  • Lessons learned in adopting endovascular techniques for treating abdominal aortic aneurysm. (Patterson MA, Jean-Claude JM, Crain MR, Seabrook GR, Cambria RA, Rilling WS, Towne JB) Arch Surg 2001 Jun;136(6):627-34 PMID: 11386998 06/26/2001
  • Hemodialysis catheter placement directly into occluded central vein segments: a technical note. (Horton MG, Mewissen MW, Rilling WS, Crain MR, Bair D) J Vasc Interv Radiol 1999 Sep;10(8):1059-62 PMID: 10496708 09/25/1999
  • Puncture-induced deformity of a metallic stent within a dialysis access graft causing thrombotic failure: case report and description of salvage. (Lane JD, Rilling WS, Crain MR, Mewissen MW) J Vasc Interv Radiol 1998 Sep-Oct;9(5):837-9 PMID: 9756076 10/02/1998
  • Helical computed tomography of the normal thoracic outlet. (Matsumura JS, Rilling WS, Pearce WH, Nemcek AA Jr, Vogelzang RL, Yao JS) J Vasc Surg 1997 Nov;26(5):776-83 PMID: 9372815 12/31/1997
  • Gated cardiac MR imaging and P-31 MR spectroscopy in humans at 1.5 T. Work in progress. (Grist TM, Kneeland JB, Rilling WR, Jesmanowicz A, Froncisz W, Hyde JS) Radiology 1989 Feb;170(2):357-61 PMID: 2911658 02/01/1989
  • Last update: 09/13/2017
    jenkins-FCD Prod-132 e0edc266de37dd13c3a3aec79eb87f3c7abc6fa4